Cargando…
Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization
BACKGROUND: At the diagnosis of hepatocellular carcinoma (HCC), more than 90% of HCC patients present cirrhosis, a clinical condition often associated to malnutrition. Sarcopenia is an indirect marker of malnutrition assessable on computed tomography (CT). AIM: To evaluate the prognostic value of sa...
Autores principales: | Roth, Gael, Teyssier, Yann, Benhamou, Maxime, Abousalihac, Mélodie, Caruso, Stefano, Sengel, Christian, Seror, Olivier, Ghelfi, Julien, Seigneurin, Arnaud, Ganne-Carrie, Nathalie, Gigante, Elia, Blaise, Lorraine, Sutter, Olivier, Decaens, Thomas, Nault, Jean-Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521519/ https://www.ncbi.nlm.nih.gov/pubmed/36185630 http://dx.doi.org/10.3748/wjg.v28.i36.5324 |
Ejemplares similares
-
Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Roth, Gaël S., et al.
Publicado: (2021) -
Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma
por: Roth, Gaël Stéphane, et al.
Publicado: (2020) -
Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation
por: Gigante, Elia, et al.
Publicado: (2022) -
Safety and Efficacy of Transarterial Chemoembolization in Elderly Patients with Intermediate Hepatocellular Carcinoma
por: Roth, Gael S., et al.
Publicado: (2022) -
New insights into the pathophysiology and clinical care of rare primary liver cancers
por: Gigante, Elia, et al.
Publicado: (2020)